Toward a better understanding of the mechanisms and pathophysiology of anhedonia: are we ready for translation?

DA Pizzagalli - American Journal of Psychiatry, 2022 - Am Psychiatric Assoc
Anhedonia—the loss of pleasure or lack of reactivity to pleasurable stimuli—remains a
formidable treatment challenge across neuropsychiatric disorders. In major depressive …

The biology of human resilience: Opportunities for enhancing resilience across the life span

A Feder, S Fred-Torres, SM Southwick, DS Charney - Biological psychiatry, 2019 - Elsevier
Recent scientific and technological advances have brought us closer to being able to apply
a true biopsychosocial approach to the study of resilience in humans. Decades of research …

[HTML][HTML] Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2

JP Lopez, MD Lücken, E Brivio, S Karamihalev, A Kos… - Neuron, 2022 - cell.com
A single sub-anesthetic dose of ketamine produces a rapid and sustained antidepressant
response, yet the molecular mechanisms responsible for this remain unclear. Here, we …

Neurobiology of resilience: interface between mind and body

F Cathomas, JW Murrough, EJ Nestler, MH Han… - Biological …, 2019 - Elsevier
Stress-related neuropsychiatric disorders, such as major depressive disorder and
posttraumatic stress disorder, exact enormous socioeconomic and individual consequences …

Resilience in the age of COVID-19

H Kaye-Kauderer, JH Feingold, A Feder… - BJPsych …, 2021 - cambridge.org
Resilience is broadly defined as the ability to bounce back from adversity or trauma. Recent
advances in resilience research have shifted away from merely describing individual …

Role of mesolimbic brain-derived neurotrophic factor in depression

JW Koo, D Chaudhury, MH Han, EJ Nestler - Biological psychiatry, 2019 - Elsevier
Brain-derived neurotrophic factor (BDNF) is widely accepted as being critical for neural and
synaptic plasticity throughout the nervous system. Recent work has shown that BDNF in the …

Selective kappa-opioid antagonism ameliorates anhedonic behavior: Evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)

DA Pizzagalli, M Smoski, YS Ang, AE Whitton… - …, 2020 - nature.com
Anhedonia remains a major clinical issue for which there is few effective interventions.
Untreated or poorly controlled anhedonia has been linked to worse disease course and …

Activation of parabrachial nucleus-ventral tegmental area pathway underlies the comorbid depression in chronic neuropathic pain in mice

L Zhang, J Wang, C Niu, Y Zhang, T Zhu, D Huang… - Cell reports, 2021 - cell.com
Depression symptoms are often found in patients suffering from chronic pain, a
phenomenon that is yet to be understood mechanistically. Here, we systematically …

Impact of the KCNQ2/3 channel opener ezogabine on reward circuit activity and clinical symptoms in depression: results from a randomized controlled trial

S Costi, LS Morris, KA Kirkwood… - American Journal of …, 2021 - Am Psychiatric Assoc
Objective: Preclinical studies point to the KCNQ2/3 potassium channel as a novel target for
the treatment of depression and anhedonia, a reduced ability to experience pleasure. The …

Ion channel dysfunction and neuroinflammation in migraine and depression

E Eren-Koçak, T Dalkara - Frontiers in Pharmacology, 2021 - frontiersin.org
Migraine and major depression are debilitating disorders with high lifetime prevalence rates.
Interestingly these disorders are highly comorbid and show significant heritability …